Screening for Pulmonary Embolism Using Single-channel Electrocardiogram
NCT07412418
Cardiovascular Diseases, Chronic Disease
Moscow, Russia
View Trial DetailsNCT Number: NCT06756373
To assess to which extent we are adherent to ESC guidelines 2019 in management of patients presented with acute pulmonary embolism
Trial opening soon.
Get NotifiedAll sexes
Observational
Pulmonary embolism (PE) is the third most frequent cardiovascular disease and is associated with a high mortality burden PE is defined as the obstruction of a pulmonary artery, mostly resulting from the dislodgement of thrombotic material from the lower limbs. It has a wide variety of presentations, ranging from an asymptomatic incidental finding to circulatory collapse and sudden death Pulmonary embolism response teams (PERTs) have emerged as a multidisciplinary team for managing acute pulmonary embolism, with a rapid activation process for multimodality assessment, risk stratification and best management especially for complex challenge cases. PERTs help in improving time to PE diagnosis; shorter time to initiation of anticoagulation reducing hospital length of stay, increasing use of advanced therapies as catheter directed therapies without an increase in bleeding complications with decreasing mortality
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 day
mortality rate of pulmonary embolism
Contact information is provided by the study sponsor or research team.
Assiut University
Other
Adherence to International Guidelines Directed Risk Stratification and Management of Acute Pulmonary Embolism, an Egyptian Experience
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07412418
Cardiovascular Diseases, Chronic Disease
Moscow, Russia
View Trial DetailsNCT07560293
Cardiovascular Diseases, Disease
View Trial DetailsNCT07527117
Cardiovascular Diseases, Disease
Boston, Massachusetts, United States
View Trial DetailsNCT07473284
Cardiovascular Diseases, Catheter Thrombosis
View Trial Details